Osteocyte viability with glucocorticoid treatment: relation to histomorphometry.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 14644862.
- Also identified by PMC identifier 1754416.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Glucocorticoid induced osteoporosis is a common clinical problem. To determine the pathophysiology of glucocorticoid induced osteoarthritis at the organ level. Iliac crest biopsy specimens were obtained from nine patients receiving prednisone treatment for rheumatoid arthritis. Osteocyte viability and histomorphometric indices were assessed. Compared with controls, glucocorticoid treated subjects had reduced trabecular thickness and increased erosion. The number of viable osteocytes was significantly decreased in glucocorticoid treated patients compared with controls. The impaired bone formation, increased erosion and, importantly, loss of viable osteocytes are all likely to contribute to the increased risk of fracture in these patients.
Medical subject headings
- Anti-Inflammatory Agents
- Glucocorticoids
- Osteoarthritis
- Osteocytes
- Prednisolone